Pyxis Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Pyxis Oncology has a total shareholder equity of $125.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $173.7M and $48.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$119.30m |
| Equity | US$125.70m |
| Total liabilities | US$48.02m |
| Total assets | US$173.73m |
Recent financial health updates
Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?
Feb 18
Here's Why We're Watching Pyxis Oncology's (NASDAQ:PYXS) Cash Burn Situation
Sep 01We're Hopeful That Pyxis Oncology (NASDAQ:PYXS) Will Use Its Cash Wisely
Apr 13Recent updates
Pyxis Oncology: Data Arriving Later Than Expected, But May Be Worth The Wait
Mar 28Pyxis Oncology: Making A Bold Acquisition Move, But It's Not A Convincing Thesis
Jan 18Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?
Feb 18Here's Why We're Watching Pyxis Oncology's (NASDAQ:PYXS) Cash Burn Situation
Sep 01Pyxis Oncology GAAP EPS of -$0.79 beats by $0.06
Aug 15We're Hopeful That Pyxis Oncology (NASDAQ:PYXS) Will Use Its Cash Wisely
Apr 13Financial Position Analysis
Short Term Liabilities: PYXS's short term assets ($124.6M) exceed its short term liabilities ($25.8M).
Long Term Liabilities: PYXS's short term assets ($124.6M) exceed its long term liabilities ($22.3M).
Debt to Equity History and Analysis
Debt Level: PYXS is debt free.
Reducing Debt: PYXS had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PYXS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PYXS has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 48.5% each year.